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ABSTRACT
Efficient construction of BAC-based human artificial
chromosomes (HACs) requires optimization of each
key functional unit as well as development of tech-
niques for the rapid and reliable manipulation of
high-molecular weight BAC vectors. Here, we have
created synthetic chromosome 17-derived alpha-
satellite arrays, based on the 16-monomer repeat
length typical of natural D17Z1 arrays, in which the
consensus CENP-B box elements are either comple-
tely absent (0/16 monomers) or increased in density
(16/16 monomers) compared to D17Z1 alpha-satellite
(5/16 monomers). Using these vectors, we show that
the presence of CENP-B box elements is a require-
ment for efficient de novo centromere formation
and that increasing the density of CENP-B box
elements may enhance the efficiency of de novo cen-
tromereformation.Furthermore,wehavedevelopeda
novel,high-throughputmethodologythatpermitsthe
rapid conversion of any genomic BAC target into a
HAC vector by transposon-mediated modification
with synthetic alpha-satellite arrays and other key
functional units. Taken together, these approaches
offer the potential to significantly advance the utility
of BAC-based HACs for functional annotation of the
genome and for applications in gene transfer.
INTRODUCTION
Alpha-satellite DNA is the major species of repetitive element
foundatthecentromereofallnormalprimatechromosomes.Itis
organizedinahierarchicalstructurebasedona 171bpmono-
meric unit that is tandemly multimerized into a higher-order
repeat(HOR),whichisitselfrepeatedintandemoverhundreds
tothousandsofkilobasesinthecentromericregionofallnormal
human chromosomes [reviewed in (1–3)]. Centromeric
alpha-satellite acts to organize the recruitment of key centro-
mericproteins(CENPs)toformatrilaminarprotein–DNAcom-
plex,the kinetochore, which mediates the interactions between
the chromosome and the spindle apparatus that are responsible
for coordinated chromosome movements during cell division
(4–6). While functional kinetochores have been observed
at chromosomal locations not containing any alpha-satellite
[so-called ‘neocentromeres’; reviewed in (7)], only cloned
alpha-satellite DNA has thus far been shown to form centro-
meresdenovowhenintroducedintothecellnucleusbytransfec-
tion or microinjection in artiﬁcial chromosome assays (8–11).
The ability to create human artiﬁcial chromosomes (HACs)
was pioneered through the development of techniques to syn-
thesize large alpha-satellite arrays in vitro (12). These artiﬁcial
chromosome vectorsmay have eventual applications inhuman
gene transfer (8,13); e.g. HACs containing the HPRT genomic
locus have been shown to complement HPRT-deﬁcient cell
lines (14,15), and we have observed sustained expression of
the b-globin gene from HACs carrying the entire 150 kb
b-globin genomic region (J. Basu, unpublished data). In addi-
tion, HACs incorporating the GCH1 locus have been shown to
reproduce the expression pattern of GCH1 in vivo (16).
Finally, artiﬁcial chromosome vectors provide a methodolo-
gical platform for the identiﬁcation and functional analysis of
genomic elements in alpha-satellite that are critical for
centromere function (9,12,17–20).
Two fundamentally different approaches have been deve-
loped for the creation of HACs: top down, whereby an existing
chromosomeissystematicallyshortenedbytelomere-mediated
truncation (21); bottom up, whereby cloned chromosomal
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telomeric DNA and genomic DNA, are preassembled into a
deﬁned YAC- or BAC-based artiﬁcial chromosome vector or
are assembled by the host cell through a combination of non-
homologous recombination and DNA repair mechanisms
[reviewed in (22)]. BAC-based artiﬁcial chromosomes
may be either linear or circular and minimally require only a
mammalian selectable marker and a cloned alpha-satellite
array, which may be of natural or synthetic origin (9,23).
Variation in the efﬁciency of de novo centromere formation
between alpha-satellite templates derived from different
human chromosomes (9,19,24) have suggested a causal link
between the density of sequence elements, such as CENP-B
boxes, and de novo centromere seeding efﬁciency (25). The
CENP-B box is the biochemically deﬁned motif ‘PyTTCGT-
TGGAAPuCGGGA’ minimally responsible for mediating
binding of the constitutive centromeric protein CENP-B to
human alpha-satellite DNA (26,27).
In order to address the functional signiﬁcance of the
CENP-B box in human alpha-satellite and in HAC formation,
we have developed methodologies to directly vary the density
and distribution of CENP-B boxes in the D17Z1 chromosome
17-derived HOR unit, which in its natural conﬁguration con-
tains a CENP-B box in 5 of its 16 constituent monomers (28).
We have constructed entirely synthetic D17Z1-based derivat-
ives in which each of the 16 tandem monomeric repeats
contains either a consensus CENP-B box or a mutated
sequence element that does not bind CENP-B (29,30).
Here, we report that the efﬁciency of formation of HACs is
proportional to the density of CENP-B boxes in the HAC
vector, thus demonstrating a dependence on CENP-B boxes
in centromeric chromatin assembly.
In addition, we describe the development of a novel, single-
step, transposition-based technique for retroﬁtting genomic
BACs with synthetic alpha-satellite arrays and other key
chromosomal components using a modiﬁed Tn5 transposon
vector (31). We have established the conditions required to
mediate successful transfer of a functionally competent 86 kb
alpha-satellite array with head-to-head oriented telomeres and
selectable markers into a 100–200 kb genomic BAC. These
BAC–HAC constructs can be introduced into cultured
mammalian cells and are shown to be capable of forming
synthetic artiﬁcial chromosomes de novo. Data on the
composition, stability and function of these HACs demon-
strate that transposon-mediated retroﬁtting of genomic BACs
is an effective and universally applicable methodology for
converting any genomic BAC into a HAC vector. Taken
together, these approaches have signiﬁcant implications for
the design and further development of HACs for potential
applications in gene transfer and functional genomics.
MATERIALS AND METHODS
Synthesis of modified 2.7 kb D17Z1 repeats
The sequence of the 2.7 kb D17Z1 HOR (28) was modiﬁed
such that each of the 16  171 bp monomer units contained the
consensus CENP-B box element 50-TTT CGT TGG AAA
CGG GA-30 (26) or the Y alpha-satellite derived null element
AGA TGG TGG AAA AGG AA. Each of the 16 modiﬁed
monomerunitswasthensynthesizedbyligationoftwotothree
pairs of overlapping oligonucleotides (Operon Technologies,
CA). Pairs of engineered monomer units were then ligated
together appropriately to form dimers, such that a given mono-
mer n would be ligated to monomer (n + 1) or (n   1). In
addition, the EcoRI sites of monomers 1 and 16 were altered to
create a BamHI site at the 50 end of monomer 1 and a BglII site
at the 30 end of monomer 16 (12). Each gel-puriﬁed dimer was
then PCR ampliﬁed with a BsaI or SapI restriction site such
that upon digestion each dimer would produce a deﬁned over-
hang exactly complementary to an overhang in the adjacent
dimer. The resultant tetramers (containing no extraneous
sequence) were then T/A subcloned into pGem-Teasy
(Promega) and sequence veriﬁed. These tetrameric subunits
were then ligated together in the appropriate orientation, using
SapI(or NotI and SapI formonomers 1and 16), to generate the
required overhang. Finally, the resultant octamers were further
gel puriﬁed and ligated together to produce the completed
synthetic 16mer, representing a single synthetic D17Z1 repeat
unit, with NotI overhangs. This repeat unit was then subcloned
as a NotI fragment into the BAC cloning vector pBeloBAC11
(32). The overall strategy is outlined in Figure 1A.
Directional multimerization of the CENP-B box
enriched/null repeat units
The 2.7 kb CENP-B box enriched or CENP-B box null
synthetic D17Z1 repeat was multimerized directionally as
follows. The cloned synthetic repeat (in pBeloBAC11, as
outlined above) was digested with BglII and SpeI, and this
band (fragment ‘A’) was gel puriﬁed by standard procedures
(Qiagen). A second fragment (fragment ‘B’) was generated by
digesting the same cloned repeat with BamHI and SpeI.
The appropriate fragment ‘B’ was subsequently gel puriﬁed
and ligated to fragment ‘A’. This ligation reaction was trans-
formed into Escherichia coli (GibcoBRL), and recombinant
clones were identiﬁed by NotI digestion and pulsed-ﬁeld
gel electrophoresis (Figure 1B). This process was repeated
iteratively to create clones containing 4, 8, 16 and 32 copies
of the CENP-B box enriched/CENP-B box null repeat unit in
pBeloBAC (Figure 1C). Finally, for use as a selectable marker
in mammalian cells, a cDNA cassette conferring resistance to
puromycin was introduced into each clone by transposition
into the pBeloBAC vector backbone.
A  86 kb synthetically assembled alpha-satellite array,
derived from directional multimerization of the naturally
occurring D17Z1 repeat unit (12), was subcloned as a
BamHI/BglII fragment into the BamHI site of pBeloBAC11.
This construct was further modiﬁed by transposition with the
puromycin resistance selectable marker, as above. The struc-
turalintegrityofall modiﬁed arrays andofthe originalD17Z1-
based array was conﬁrmed by sequencing, restrictiondigestion
and ﬂuorescence in situ hybridization (FISH) [as described in
(12)], using the array as probe.
Mobility shift analysis
The effect of the mutations described above on CENP-B bind-
ing to the synthetic repeat units was evaluated by a gel mobil-
ity shift assay. Cloned tetramer units assembled from CENP-B
box enriched and CENP-B box null monomers were digested
with NotI and the inserts were gel puriﬁed. After incubation
with puriﬁed recombinant CENP-B protein (Diarect,
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Figure 1. (A)OutlineofiterativeschemeforsynthesisofmutatedversionsofD17Z1alpha-satellitearrays.Eachofthe16individualmonomerscomprisingasingle
2.7 kb higher-order repeat (HOR) was synthesized as 2–3 oligonucleotide pairs (60–100 bp each), which were directly ligated together and gel purified. Adjacent
HORs were subsequently ligated to form dimers as shown, and PCR modified to introduce SapI recognition sites at both ends as appropriate. Digestion with SapI
allows seamless ligation of adjacent dimers to create tetramers without introduction of extraneous non-alpha-satellite sequences. Two additional rounds of serial
ligation resulted in formation of a complete synthetic HOR, which was subcloned into the BAC vector pBeloBAC. (B) Outline of scheme for directional
multimerization of mutated HORs. A synthetic, 86 kb alpha-satellite array consisting of 32 tandem copies of the HOR was created as follows. pBAC17a1
wasdigestedwithBglIIandSpeIandthealpha-satellitecontainingfragment(fragment‘A’)wasisolatedandgelpurified.Thesameconstructwasseparatelydigested
withBamHIandSpeI,andthelargerfragment(fragment‘B’)wasisolatedandgelpurified.Ligationoffragment‘A’tofragment‘B’isdirectional,resultinginhead-
to-tail multimerization of adjacent repeats. The resulting pBAC17a(n + 1) construct was then isolated following transformation of the ligation reaction into E.coli.
ThisprocesswasrepeatediterativelytocreatethefinalpBAC17a32arrays.(C)Pulsed-fieldgelelectrophoresis(PFGE)analysisofintermediatesintheconstruction
of17a32HOR/BeloBACconstructs.EachintermediatewasdigestedwithNotI,whichdropsouttheentiresubclonedalpha-satellitearrayfromthepBeloBACvector
backbone.Eachlaneshowsthecompletedintermediateenrouteto32copiesofthemutatedHOR.Thenumberbeneatheachlanecorrespondstothenumberofcopies
ofthe HORineach construct,andthearrowsto the rightindicatethesizeofthe alpha-satelliteinsertandthevector backbone. Theinsertin lanelabeled‘1’is2.7 kb
and therefore too small to be resolved by PFGE.
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buffer (26), protein–DNA complexes were electrophoresed
through a 2% agarose gel in 0.5· TBE buffer. Following
electrophoresis, a SybrGold (Molecular Probes) stain was
used to visualize DNA bands.
Transposon engineering
BAC-based transposon vectors containing synthetic centro-
meric and telomeric arrays were constructed as follows.
Selectable markers encoding resistance to neomycin/
kanamycin and puromycin were subcloned as PCR products
into the PstI and SmaI sites, respectively, of the pMod trans-
poson vector (Epicentre). This modiﬁed transposon cassette
was PCR-ampliﬁed tointroduceBglII overhangs on either side
and subcloned into the BamHI site of the BAC vector
pBeloBAC11. Synthetic telomeric DNA was then subcloned
into the BAC transposon vector such that two 800 bp telomere
seeds were arranged in a head-to-head orientation separated by
an adapter containing the recognition site for the ultrarare
restriction enzyme I-CeuI (NEB). A synthetically assembled
D17Z1-based array (12) was subcloned into the BamHI site of
the BAC-based transposon vector. The structure of the ﬁnal
transposon vector construct pBAC17a32 HTH Tel TN was
conﬁrmed by extensive restriction analysis, sequencing and
Southern blotting (data not shown). Independent versions of
this transposon vector were created for the CENP-B box
enriched and CENP-B box null synthetic arrays described
above, in addition to the natural D17Z1 array.
Preparation of the transposon
Digestion of the transposon vector with PshAI (NEB) releases
a linear transposon containing an 86 kb alpha-satellite array,
neo/kan and puroR selectable markers, and synthetic
telomeres in a head-to-head orientation (Figure 3). The trans-
poson fragment was separated by agarose gel electrophoresis,
isolated in a gel slice and puriﬁed by standard techniques.
Transposition reaction
A collection of genomic BAC clones of average insert size
100–150 kb was created by shotgun subcloning a NotI digest
of whole genomic DNA from human HT1080 cells into the
BAC vector VJ104, a BAC108L derivative (12). The chromo-
somal origin of each genomic fragment was established by
direct sequencing of each genomic insert and comparison to
public sequence databases. In addition, BAC 2202F23 was
identiﬁed by a BLAST search of the HTGS database through
NCBI with the human growth hormone (HGH) cDNA
sequence. These genomic BACs were used as targets for
transposon-mediated modiﬁcation to establish the feasibility
of transposition as a simple, one-step methodology for con-
verting genomic BACs into HAC vectors.
Transposition reactions were extensively optimized to
determine the ideal reaction volume, total amount of DNA,
molar ratio of transposon to target, reaction conditions and
transformation conditions. The entire transposition reaction
was electroporated into DH10B E.coli and plated onto
Cm/kan plates to select for successful transposition events.
Individual colonies were miniprepped and screened by NotI
digestion to establish if the transposon had integrated into the
genomic insert or the BAC vector backbone. Both classes of
integrants could be readily obtained without extensive initial
screening. Clones were further screened by digestion with
EcoRI, PstI, PvuII and HindIII to conﬁrm the presence of
D17Z1 alpha-satellite DNA in the genomic BAC. For clones
with integration events in the genomic insert, sequencing with
transposon-based primers was used to directly establish the
site of integration of the transposon.
Cell transfection
Human HT1080 cells were transfected using Fugene 6
(Roche) reagent according to the manufacturer’s instructions
and stable clones were identiﬁed on the basis of resistance
to puromycin (Kayla) at 3 mg/ml. Clones appeared after
7–10 days and were subsequently expanded to generate clonal
lines for further analysis.
Cytogenetic analysis and validation of HACs
Clonal populations of cells containing putative HACs were
analyzed as described (9,12,17,19). HACs were considered
validated if they showed a positive hybridization signal
with a FISH probe derived from the synthetic array as well
as positive immunoreactivity for CENP-C, a centromere pro-
tein localized to the outer kinetochore and speciﬁc for active
centromeres (12,33), and if they were mitotically stable.
Brieﬂy, cells were arrested at metaphase using colchicine
(Gibco) at 40 mg/ml for 45 min at 37 C, then treated with
hypotonic solution (0.075 M KCl, 12 min, 37 C) and applied
toslidesusingaShandonCytospin3.Slidesweresubsequently
ﬁxed in 2% formaldehyde and immunoreacted with rabbit
anti-CENP-C antibody (12) at a dilution of 1/2000 in PBS
and detected with goat anti-rabbit IgG (Molecular Probes).
DNA probes were labeled by nick-translation using the
Vysis system according to the manufacturer’s instructions.
Immunoreacted slides were ﬁxed (3:1, methanol:acetic acid),
subjected to denaturation (70% formamide, 72 C, 8 min) and
hybridized to denatured probes as described (9,12). Mitotic
stability was evaluated by cytogenetic analysis after growth in
the presence or absence of drug selection for up to 6 weeks.
RESULTS
Previous studies have established that vectors containing mul-
tiple copies of certain alpha-satellite arrays can seed formation
of de novo centromeres in human HT1080 cells (12,20). How-
ever, the overall frequency of generation of HACs has been
reported to be variable and often quite low (9,17,18,24,34).
Therefore, we have undertaken to develop a general approach
to increase the efﬁciency of HAC formation and to evaluate
the sequence dependency of de novo centromere seeding.
Construction of engineered, D17Z1-based HAC vectors
The BAC–HAC system provides a platform to systematically
evaluate the functional signiﬁcance of sequence elements
within human alpha-satellite DNA. We developed methodo-
logies to construct modiﬁed, synthetic D17Z1 repeat units that
are either enriched for or depleted in the density of CENP-B
box DNA binding elements. In order to generate engineered
repeat units, each of the 16 monomers was synthesized by the
serial, stepwise assembly of oligonucleotide pairs, each
between 60 and 100 bp in length, as shown in Figure 1A.
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to form dimers. This process of PCR and ligation assembly
was serially repeated until the complete 16-monomer HOR
was constructed (see Materials and Methods). The resulting
synthetic repeat was then subcloned and directionally concat-
amerized to 32 copies (Figure 1B and C), using methods
previously developed in our laboratory (12).
CENP-B boxes are required for efficient centromere
formation de novo
We used the techniques described above to create a modiﬁed
variant of D17Z1 alpha-satellite in which all of the consensus
CENP-Bboxesorelementsresemblingtheconsensusineachof
the 16 monomer units were replaced with a sequence derived
from Y chromosome alpha-satellite. As Y alpha-satellite does
not bind CENP-B (30), this approach allowed us to knock out
anyinteractionbetweenCENP-Banditsbiochemicallydeﬁned
consensuselement,aswellasanyinteractionsbetweenCENP-B
and elements resembling the consensus that might potentially
occurinvivo.ConﬁrmationofabolishmentofCENP-Bbinding
tothesyntheticrepeatwasshownbylossofmobilityshiftinagel
shift assay (data not shown).
Constructs based on the naturally occurring, unmodiﬁed
D17Z1 repeat have been used previously to generate mitotic-
ally stable HACs in 10–50% of drug-resistant HT1080 clones
after transfection (9,12,17,24). Here, cytogenetically detect-
able HACs were identiﬁed in 4 of 38 colonies (Table 1,
Figure 2), consistent with previous studies. However, when
using the CENP-B null construct in which all CENP-B boxes
had been modiﬁed, only a single clone was identiﬁed to have a
putative de novo centromere out of 40 clones screened
(Table 1). The fact that the observed rate of de novo HAC
formation is low but is not zero is consistent with other reports
that some alpha-satellite arrays that do not contain CENP-B
boxes may form apparent HACs at very low frequencies
(24,34); however, this single clone (as well as those in the
literature) may represent a false positive that has acquired
HT1080 alpha-satellite from an endogenous chromosome,
as documented by us previously (9). This point notwithstand-
ing, our data indicating a dependence on CENP-B boxes are in
agreementwith Masumotoandcolleagues,whousedanaltern-
ative approach to modify CENP-B boxes in a repeat unit
derived from chromosome 21 (18). Combined, the two studies
provide strong evidence that CENP-B boxes are required for
efﬁcient formation of de novo centromeres in HAC systems.
As a corollary to the data presented above and by Ohzeki
et al. (18), we reasoned that if the density of CENP-B boxes
was indeed critical forde novo centromere formation, it should
be possible to create synthetic alpha-satellite arrays with a
CENP-B box density even higher than their naturally occur-
ring counterparts. These novel synthetic arrays might form a
more efﬁcient template for centromere formation de novo than
arrays with the natural density of CENP-B box elements. To
test this hypothesis, we used the strategy described above to
construct a synthetic D17Z1-derived alpha-satellite array sat-
urated with CENP-B boxes such that each of the 16 monomers
in the D17Z1 repeat contained a consensus CENP-B box.
Upon introduction into HT1080 cells, these saturated synthetic
arrays formed HACs de novo more than twice as efﬁciently as
arrays containing the natural density of CENP-B boxes
(Table 1) (P < 0.09, Fisher’s exact test) and almost nine
times as efﬁciently as arrays without CENP-B boxes
(P < 0.01, Fisher’s exact test). Although the HAC formation
frequency of the latter in this particular study does not differ
signiﬁcantly from that of arrays containing the natural density
of CENP-B boxes (P = 0.14, Fisher’s exact test), the overall
trends nonetheless demonstrate that the rates of de novo
Figure 2. Cytogenetic analysis of HACs from synthetic chromosome 17-derived alpha-satellite arrays. Arrows designate HACs. Immunostaining with an anti-
CENP-C antibody (green) identifies functional centromeres. FISH with the synthetic alpha-satellite as probe (red) hybridizes with the HAC as well as to the
centromeres of the endogenous HT1080 chromosome 17s. (HT1080 is quasitetraploid, so there are four copies of the endogenous chromosome 17s.) DAPI-stained
chromosomes are shown in blue. (A) HT1080 clone generated by transfection with pBAC17a32-all construct (Table 1) showing the presence of two HACs.
(B)HT1080clonegeneratedbytransfectionwithpBAC17a32-natural.AsingleHACisvisible.(C)HT1080clonegeneratedbytransfectionwithpBAC17a32-null.
Two HACs are present.
Table 1. Effect of CENP-B box density on rate of HAC formation
Vector No. of
CENP-B
boxes
No. of
experiments
No. of
clones
analyzed
No. of
clones
with
HACs
a
HAC
formation
(%)
pBAC17a32-all 16 15 45 10 22
pBAC17a32-natural 5 6 38 4 10.5
pBAC17a32-null 0 10 40 1 2.5
Materials and Methods).
aCytogenetically detectable. Validated by FISH and mitotic stability (see
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CENP-B box and that arrays saturated for the CENP-B box
clearly form de novo centromeres more effectively than arrays
lacking the CENP-B box, conﬁrming and extending previous
studies based on chromosome 21 (18). The frequencyof HACs
within any one clone was observed to vary from 10 to 100%,
similar to the ranges observed in cell lines derived from
transfection with control natural arrays (9,20,23).
Consistent with other studies, cytogenetic estimates sugges-
ted that the detected HACs (from all versions of the array) are
several megabases in size (Figure 2). In all cases, HACs were
shown to be mitotically stable in the absence of selection for
6 weeks and to bind the centromere-speciﬁc protein CENP-C
(Figure 2 and data not shown). Thus, the effect of changing
the density of CENP-B boxes appears to be limited to the
efﬁciency of formation of HACs and not to their subsequent
behavior in mitotic segregation. More subtle effects on non-
disjunction or chromosome lag (17), however, could not be
assessed with the techniques used in this study.
Retrofitting of genomic BACs by transposition with
synthetic alpha-satellite arrays
TheutilityofHACvectorsforgenetransferwouldbeimproved
by enhancing the ability to combine elements capable of efﬁ-
cient de novo centromere formation with genomic fragments
containing genes or other elements of interest. Thus, we next
proceededtodevelopstrategiesfortherapidintroductionofthe
various CENP-B box optimized alpha-satellite arrays into
genomicBACs.Figure3showsthecriticalfunctionalelements
inpBAC17a32HTHTelTN.Digestionofthisconstructwiththe
restriction enzyme PshAI results in the release of a transposon
containing the 86 kb synthetic alpha-satellite array, as well as
800bptelomereseedsthatarecapable(uponlinearizationwith
I-CeuI)ofseedingdenovotelomeres(35).Transpositionofthis
linearfragmentintoatargetgenomicBACretroﬁtsthelatterinto
a BAC–HAC vector. We have constructed analogous trans-
poson vectors containing the original D17Z1 array, as well as
those containing the CENP-B box enriched or null versions of
the array.
The ﬁdelity of the transposition reaction was high, as >80%
of BAC clones examined showed no detectable loss or
rearrangement of genomic insert or alpha-satellite sequence,
as evidenced by extensive restriction analysis on pulsed ﬁeld
and standard gels (Figure 4). Partial loss of telomeric sequence
was occasionally observed, but recovery of retroﬁtted
BAC clones containing nearly full-length telomeres was
typically possible. We mapped the site of integration by direct
PshA1 EcoRV Iceu-1 Mlu-1 PshA1
Neo/Kan puro
TEL TEL
1 kb
ME ME
86 kb 17α 32 synthetic alpha-satellite array
Figure 3. Digestion of pBAC 17a32 HTH Tel TN with PshA1 releases the  100 kb linear transposon vector, shown with an 86 kb chromosome 17-derivedalpha-
satellitearray,aswellas 800bpsynthetictelomeresseparatedbyarecognitionsitefortheultrarareendonucleaseI-CeuI.Mammaliancelllineselectionisbasedona
pgk-purocassetteconferringresistancetopuromycinandaneo/kancassetteconferringresistancetogeneticin.Thetransposonvectorisflankedby19bptransposase
recognition elements (ME).
Figure 4. Detection and validation of transposition events in genomic BACs.
(A)IdentificationoftranspositioneventsbyNotIdigest.Lane1,targetgenomic
BAC.Lane2,transposoninsertionintogenomicregionoftargetBAC.Notethat
insert fragment excised by NotI is much larger than the starting fragment from
lane 1. Lane 3, transposon insertion into vector backbone of target BAC. Note
thatvectorfragmentismuchlargerthanthestartingvectorfragmentfromlane1,
while genomic insert fragment is unchanged. (B) Confirmation of successful
transposition of complete 86 kb alpha-satellite array. Lane 1, target BAC cut
with NotI. Lane 2, target BACcut withBamHI. Lanes 3–5,clone with putative
transposition event cut with I-CeuI (lane 3), Not I (lane 4) or BamHI (lane 5).
The86kbbandinlane5representsthesizeofthealpha-satellitearraypresentin
the clone. (C) Analysis of alpha-satellite array integrity in BAC modified by
transposition. pBAC17a32 HTH Tel TN control cut with PstI (lane 1), PvuII
(lane 2), EcoRI (lane 3) and HindIII (lane 4). Clone with putative transposition
event cut with PstI (lane 5), PvuII (lane 6), EcoRI (lane 7) and HindIII(lane 8).
BothPstIandPvuIIdigestsgenerateamulticopy2.7kbHORfragmentfromthe
alpha-satellite array. HindIII is predictedto produce bands at 1.4 and 0.9 kb. In
A,BandC,LandHrepresentlow-molecularweightandhigh-molecularweight
markers, respectively.
592 Nucleic Acids Research, 2005, Vol. 33, No. 2sequencing outward from the transposon integration site
and documented successful transpositions into both genomic
insert and vector backbone (Figure 4) at the predicted
frequencies.
In order to assess the generality of this approach as a method
for BAC retroﬁtting, we assembled a collection of genomic
BACs containing inserts of about 100 kb derived either by
shotgun subcloning of whole genomic DNA or obtained
through the public databases. We modiﬁed each BAC with
the pBAC17a32 HTH Tel TN-derived transposon vector and
conﬁrmed the size and structural integrity of the retroﬁtted
BAC by restriction analysis and Southern blotting (Figure 4
and data not shown). We then evaluated the ability of the
resultant BAC–HAC vectors to generate HACs de novo.
Several representative BAC–HAC vectors (Table 2) were
linearized by digestion with the ultrarare endonuclease I-CeuI
and introduced into HT1080 cells by transfection. Potential
HAC formation was conﬁrmed by FISH analysis with probes
against the chromosome 17 alpha-satellite, BAC vector back-
bone, genomicinsert andtelomeric DNA,and was validated as
described above. Representative examples of such HACs are
shown in Figure 5. While the current experiments have not
rigorously addressed whether the HACs are linear or circular,
they do contain telomere repeats (Figure 5D), as predicted
from the structure of the BAC–HAC vectors used. The efﬁ-
ciency of de novo HAC formation using different BAC–HAC
vectors is summarized in Table 2 and is within the range
shown with other vectors (9,18,24).
DISCUSSION
Since the original reports of de novo centromere and
HAC formation (12,20), a number of groups have described
related approaches to further develop and optimize artiﬁcial
chromosome systems [reviewed in (8,22)]. The creation of
HACs has now been established as a tractable (if laborious)
approach to systematically identify and dissect elements that
are critical for chromosome function (17–19). In this report,
we describethe further reﬁnementofthe BAC–HACsystem as
a methodological platform to undertake a functional analysis
of the role of the density of CENP-B box elements in human
alpha-satellite DNA, as well as a novel approach for the rapid
and reliable manipulation of genomic BACs with these
synthetic arrays.
CENP-B is a constitutively present DNA-binding
protein found in the underlying centric heterochromatin of
all human chromosomes except for the Y chromosome (30).
The corresponding DNA sequence element that deﬁnes the
cognate binding site, the CENP-B box, has been identiﬁed
as PyTTCGTTGGAAPuCGGGA (26,29) and is found distrib-
uted within some, but not all, of the monomer units of
alpha-satellite DNA from human centromeres (3,34,36).
However, the role of CENP-B, if any, in specifying centro-
meric identity in endogenous chromosomes remains unsettled
(37).Ychromosome centromeresdonotassociatewith CENP-
B (30), and African green monkey centromeres lack CENP-B
boxes even though the CENP-B protein itself is present (38).
Furthermore, Cenp-B knockout mice show only modest
phenotypic effects and appear to have fully functional centro-
meres, as evidenced by the lack of chromosome missegrega-
tion phenotypes (39–41).
Nevertheless, studies of de novo centromere formation
with cloned alpha-satellite arrays appear to support a direct
correlation between the density of CENP-B boxes and the
frequency of de novo centromere formation. For example,
comparison of cloned alpha-satellite arrays from chromo-
somes Y, X, 17 and 21 show that 17- and 21-derived arrays
form de novo centromeres more efﬁciently than X- and
Y-derived arrays (9,17,24). In addition, alpha-satellite
from a CENP-B box-rich region of the chromosome 21 centro-
mere forms de novo centromeres in a HAC system, while
alpha-satellite from a neighboring CENP-B box-depleted
region is inefﬁcient (25). Further, the de novo centromere
nucleation ability of the chromosome 21-derived alpha-
satellite array can be disrupted by mutation of its constituent
CENP-B boxes (18), an outcome that parallels our observa-
tions reported here on mutation of CENP-B boxes in
chromosome 17-derived alpha-satellite. Finally, it has also
been established that CENP-B boxes outside the context of
alpha-satellite DNA are not competent to nucleate de novo
centromereassembly(18),showingthatelementsotherthanthe
CENP-B box are required for centromere function. Taken
together, our data and earlier observations unambiguously
establish the presence of CENP-B and its cognate binding
element as a critical, but not sole, element for de novo cen-
tromere formation in artiﬁcial chromosome assays.
Notwithstanding the clear role of the CENP-B box in
assembly of HACs, the role of CENP-B in its endogenous
chromosomal context remains open to debate. At least three
CENP-B-like proteins have been identiﬁed in ﬁssion yeast,
and double mutants exhibit severe chromosome segregation
defects (42). Such functional redundancy may explain the lack
of a major phenotype in mouse knockouts of Cenp-B (39–41),
and also explain why CENP-B appears dispensable for func-
tion of the Y chromosome in both mice and humans as well as
for function of neocentromeres (43). In addition, it remains to
be established whether the distribution of CENP-B boxes
within an array of monomers or even within a single monomer
is also of importance, as might be expected if CENP-B
participates in nucleosome positioning (44,45).
In addition to the effect of manipulating CENP-B boxes
demonstrated here and by Ohzeki et al. (18), it is apparent
that other sequences within alpha-satellite may inﬂuence the
efﬁciency of HAC formation, as even arrays with a similar
numberofCENP-B boxescandifferquitesubstantiallyintheir
ability to seed HACs (17,34). This possibility may now be
investigated systematically using synthetic alpha-satellite
arrays where the distribution of CENP-B boxes and/or other
sequences in each monomer has been manipulated, using the
approach outlined here.
Table 2. Examples of genomic BACs engineered by transposition
Target
genomic BAC
Chromosomal
origin
Insert size
(kb)
Transposition
site
HAC
frequency
G1 Chr 2 106 Vector 2/24 (8%)
Genomic insert 1/12 (8%)
G3 Chr 17 100 Genomic insert 1/25 (4%)
G7 Chr 15 93 Genomic insert 2/14 (14%)
2202F23 (HGH) Chr 17 156 Genomic insert 2/13 (15%)
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sequences in alpha-satellite will maximize the efﬁciency
with which BAC-based HAC vectors carrying potentially
therapeutic genes might eventually be assembled in human
cells (8,10,14). The ability to create HACs de novo from
deﬁned, synthetically assembled chromosomal components
cloned into BAC vectors may provide signiﬁcant advantages
for practical development as therapeutic agents. Unlike engin-
eered microchromosomes created by top-down methodologies
relying on the truncation and manipulation of existing human
chromosomes [reviewed in (46)], such BAC–HAC vectors can
be propagated in a massive scale in E.coli and puriﬁed using
well-established methodologies under GMP conditions, mak-
ing them suitable for immediate use as human therapeutics
(47). Once optimized, BAC-based HAC vectors may offer an
alternative approach towards analysis of gene and genome
function, gene transfer and potentially gene therapy that
may circumvent many of the problems associated with con-
ventional, retroviral-based gene delivery systems (48). Trans-
genes in viral vectors are also susceptible to position effects
and silencing (49), and the possibility of activation or knock-
out of host oncogenes or tumor suppressors during viral integ-
ration is now an empirically observed phenomenon (50).
In order for BAC-based HACs to become practical vector
systems for biotechnology or other high-throughput applica-
tions, methods for the manipulation of large (>100 kb)
genomic fragments and large repetitive arrays have to be
developed and optimized. Traditional subcloning techniques
(51) are notoriously inefﬁcient for this application, with sig-
niﬁcant levels of BAC deletion and rearrangement being rou-
tinely observed. A number of recombination-based BAC
engineering systems have been developed in an attempt to
address these concerns. For example, the Cre recombinase
hasbeen applied to the modiﬁcation ofBACswith mammalian
selectable markers (52,53), as well as to the creation of BAC-
based HACs (54). In addition, homologous recombination in
E.colihasbeen used toengineer BACswith selectable markers
(55,56). However, these approaches are probably not sufﬁ-
ciently efﬁcient or ﬂexible to make the high-throughput
conversion of BACs into BAC–HAC vectors practical.
We have therefore developed and implemented a novel
methodology for the rapid creation of unimolecular HAC vec-
tors, based on Tn5 transposons (31) and containing synthetic
alpha-satellite arrays and other key functional units. We show
in this report that this technique allows for the rapid and
reliable manipulation of target BACs and that the resultant
Figure 5. Cytogenetic analysis of HACs created from unimolecular BAC–HAC vectors. (A) Dual FISH/immunostaining with anti-CENP-C antibodies (red) and
D17Z1 probe (green). (B) Two-color FISH analysis: D17Z1 probe (green) and 150 kb genomic fragment probe from BAC–HAC vector (red). (C) Two-color FISH
analysis: D17Z1 probe (green) and BAC vector backbone probe (red). (D) Two-color FISH analysis: D17Z1 probe (green) and telomeric DNA (red). In all panels,
DAPI-stained DNA in blue.
594 Nucleic Acids Research, 2005, Vol. 33, No. 2species are capable of forming functionally validated HACs.
Such transposon vectors may be used to introduce future
iterations of optimized synthetic alpha-satellite, as well as
otherkeyfunctionalelementsimpactingartiﬁcialchromosome
formation and stability, into genomic BAC targets of interest.
Taken together, we believe that the strategies described here
will signiﬁcantly facilitate the use of BAC-based HACs for
gene transfer and functional studies of the genome.
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